Skip to content

Clinical trials

Phase 2 Febrile Neutropenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Febrile Neutropenia Phase: Phase 2 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20121
20132
20162
20173
20192
20211
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status3
Active, not recruiting2
Recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center2
Affiliated Hospital of Nantong University1
Asan Medical Center1
Biocad1
Forest Laboratories1
Gruppo Italiano Trapianto di Midollo Osseo1
Jiangsu HengRui Medicine Co., Ltd.1
Memorial Sloan Kettering Cancer Center1
Qilu Pharmaceutical Co., Ltd.1
S&D Pharma SK s.r.o.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Febrile Neutropenia18
Neutropenia7
Breast Neoplasms5
Multiple Myeloma3
Carcinoma, Non-Small-Cell Lung2
Mucositis2
Neoplasms2
Hematologic Diseases1
Lung Neoplasms1
Pseudomonas Infections1

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.